| [1] |
Mendhiratta N, Muraki P, Sisk AJ, et al. Papillary renal cell carcinoma: Review[J]. Urol Oncol,2021,39(6):327-337.
|
| [2] |
杨宏林, 胡开松, 冯常福, 等. 腹腔镜肾部分切除术与根治性切除术治疗T2a期肾癌比较研究及三年随访总结[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2022, 16(2): 133-136.
|
| [3] |
Akhtar M, Al-Bozom IA, Al HT. Papillary Renal Cell Carcinoma (PRCC): An Update[J]. Adv Anat Pathol, 2019, 26(2): 124-132.
|
| [4] |
Bahadoram S, Davoodi M, Hassanzadeh S, et al. Renal cell carcinoma: an overview of the epidemiology, diagnosis, and treatment[J]. G Ital Nefrol, 2022, 39(3).
|
| [5] |
周硕明, 甘卫东. 2022版欧洲泌尿外科学会肾细胞癌诊疗指南更新要点解读[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(2): 100-104.
|
| [6] |
Delahunt B, Eble JN, Mccredie MR, et al. Morphologic typing of papillary renal cell carcinoma: comparison of growth kinetics and patient survival in 66 cases[J]. Hum Pathol, 2001, 32(6): 590-595.
|
| [7] |
Ge X, Li M, Yin J, et al. Fumarate inhibits PTEN to promote tumorigenesis and therapeutic resistance of type2 papillary renal cell carcinoma[J]. Mol Cell, 2022, 82(7): 1249-1260.
|
| [8] |
Zhan T, Rindtorff N, Boutros M. Wnt signaling in cancer[J]. Oncogene, 2017, 36(11): 1461-1473.
|
| [9] |
Zhao EY, Jones M, Jones S. Whole-Genome Sequencing in Cancer[J]. Cold Spring Harb Perspect Med, 2019, 9(3): a034579.
|
| [10] |
Hong M, Tao S, Zhang L, et al. RNA sequencing: new technologies and applications in cancer research[J]. J Hematol Oncol, 2020, 13(1): 166.
|
| [11] |
Zhang Y, Wang X. Targeting the Wnt/β-catenin signaling pathway in cancer[J]. J Hematol Oncol, 2020, 13(1): 165.
|
| [12] |
Bugter JM, Fenderico N, Maurice MM. Mutations and mechanisms of WNT pathway tumour suppressors in cancer[J]. Nat Rev Cancer, 2021, 21(1): 5-21.
|
| [13] |
Xu X, Zhang M, Xu F, et al. Wnt signaling in breast cancer: biological mechanisms, challenges and opportunities[J]. Mol Cancer, 2020, 19(1): 165.
|
| [14] |
Zhao H, Ming T, Tang S, et al. Wnt signaling in colorectal cancer: pathogenic role and therapeutic target[J]. Mol Cancer, 2022, 21(1): 144.
|
| [15] |
Hahne JC, Valeri N. Non-Coding RNAs and resistance to anticancer drugs in gastrointestinal tumors[J]. Front Oncol, 2018, 8: 226.
|
| [16] |
M Ller V, Oliveira-Ferrer L, Steinbach B, et al. Interplay of lncRNA H19/miR-675 and lncRNA NEAT1/miR-204 in breast cancer[J]. Mol Oncol, 2019, 13(5): 1137-1149.
|
| [17] |
He Y, Jiang X, Duan L, et al. LncRNA PKMYT1AR promotes cancer stem cell maintenance in non-small cell lung cancer via activating Wnt signaling pathway[J]. Mol Cancer, 2021, 20(1): 156.
|
| [18] |
Liu H, Li D, Sun L, et al. Interaction of lncRNA MIR100HG with hnRNPA2B1 facilitates m(6)A-dependent stabilization of TCF7L2 mRNA and colorectal cancer progression[J]. Mol Cancer, 2022, 21(1): 74.
|
| [19] |
Liu S, Sun Y, Hou Y, et al. A novel lncRNA ROPM-mediated lipid metabolism governs breast cancer stem cell properties[J]. J Hematol Oncol, 2021, 14(1): 178.
|
| [20] |
Wu Q, Ma J, Wei J, et al. lncRNA SNHG11 promotes gastric cancer progression by activating the wnt/¦â-catenin pathway and oncogenic autophagy[J]. Mol Ther, 2021, 29(3): 1258-1278.
|
| [21] |
Trevisani F, Floris M, Vago R, et al. Long Non-Coding RNAs as novel biomarkers in the clinical management of papillary renal cell carcinoma patients: a promise or a pledge?[J]. Cells, 2022, 11(10): 1658.
|
| [22] |
孔党伊, 王伟, 郝敏. 非编码RNA在宫颈癌患者预后评估中的价值 [J/OL]. 中华妇幼临床医学杂志(电子版), 2020, 16(5): 615-620.
|
| [23] |
Piipponen M, Nissinen L, Riihilä P, et al. p53-Regulated long noncoding RNA PRECSIT promotes progression of cutaneous squamous cell carcinoma via stat3 signaling[J]. Am J Pathol, 2020, 190(2): 503-517.
|
| [24] |
Yang F, Song Y, Ge L, et al. Long non-coding RNAs as prognostic biomarkers in papillary renal cell carcinoma[J]. Oncol Lett, 2019, 18(4): 3691-3697.
|
| [25] |
Zhu J, Huang Q, Peng X, et al. Identification of LncRNA prognostic signature associated with genomic instability in pancreatic adenocarcinoma[J]. Front Oncol, 2022, 12: 799475.
|
| [26] |
Feng L, Yang J, Zhang W, et al. Prognostic significance and identification of basement membrane-associated lncRNA in bladder cancer[J]. Front Oncol, 2022, 12: 994703.
|